- Touch upon current topics in breast cancer screening
- More individualized screening system for breast cancers are focused upon
- Possible understand background and advances on the risk reduction of breast cancers
Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening.
A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy.
This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening.
A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. An in-depth review of these modalities is summarised in this book.
In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.
Table of Contents- Advances in Breast Cancer Screening: Precision, Imaging, and Harms
- Breast Cancer Risk Assessment Models and Multi-Cancer Early Detection Tests
- Hereditary Breast Cancer and Pathogenic Germline Variants
- Over-Diagnosis and Breast Cancer Screening
- Breast Cancer Screening with MRI in Women with Over 20% Lifetime Risk
- MRI for Breast Cancer Screening: Technical Consideration
- Risk-Reducing Surgery for Breast Cancer
- Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer
- Biomarkers in Proteomics
- Ultrasound in Breast Cancer Screening
- Detection of Breast Cancer by PET
- Inverse Scattering Problem and Microwave Mammography
- Photoacoustic Imaging of Breast Cancer
- Japanese Breast Cancer Screening: Challenges and Hopes
